CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern
Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.
Source: news-medical.net
Stay updated with breaking news from Clinical Developmentstudy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.